We can ill afford more of the same from these institutions. The stakes are too high, and the fallout is too great, for the status quo to endure. We deserve justice, not more excuses and more attempts to deprive us of the medicines we have a right to receive.
"This deal is going to end up looking either very smart or very stupid."
This little-known practice is driving up healthcare costs.
According to a new study in JAMA, there is no evidence that the majority of the U.S. Food and Drug Administration-approved cancer drugs over the last five years work.
The fight over prescription drug prices is only just beginning.
LONDON/NEW YORK, April 28 (Reuters) - U.S. drugmaker Pfizer Inc approached Britain's AstraZeneca Plc two days ago to reignite
"You feel helpless, almost like the world's gone mad," she recalled. "This isn't happening. Surely, in the U.S. and the U.K
I'm from Bangladesh and 27 years old. I was born in a society where anyone hardly heard the word C-A-N-C-E-R. So in face of impossible odds my physician suggested chemotherapy accompanied by Rituxan (a biologic drug), but I was unable to afford it because the drug costs a fortune.
In their Intellectual property case, the pharmaceutical company Novartis was asking to block a generic form of their cancer drug Gleevec from being created and sold by India. As a writer and also a person living with chronic myelogenous leukemia, I understand both sides of the battle.
But what if you want to incentivize investment in bold new drugs instead of me-too drugs? What if you want to encourage research into new areas that tangibly improve people's health? Then maybe, like India, you would only grant patents when that higher standard is met.
University of Miami Employee, Manuel Pacheco, Allegedly Looted Pharmacy For Over $14 Million In Cancer Drugs
Watch the video footage below He's pleaded not guilty to charges of four counts of grand theft, two counts of trafficking